[Permanent interstitial implantation of 125iodine in case of carcinomas of the oral cavity and the oropharynx. Preliminary report].
The authors present their first experiences gained during the last year with the permanent implantation of 125iodine seeds in thirty patients suffering from carcinomas of the oral cavity and the oropharynx. The properties and advantages of 125iodine, the method of implantation, the dosimetry and the problems of radioprotection are particularly underlined. In every case, we apply pre- or postoperative external radiotherapy, i.e. we expose the primary tumor to a dose of 50 Gy fractionated in the usual manner over four or five weeks. This combined treatment is intended to overcome the resistance to therapy of ORL malignomas and to obtain a high local rate of tumor control and a low rate of functional and cosmetic troubles.
D001918:Brachytherapy; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009062:Mouth Neoplasms / Q000532:radiotherapy*; D009960:Oropharynx / Q000528:radiation effects; D010610:Pharyngeal Neoplasms / Q000000981:diagnostic imaging*; D011859:Radiography; D011879:Radiotherapy Dosage
D007457:Iodine Radioisotopes
Die interstitielle 125Jod-Permanentimplantation bei Mundhöhlen- und Oropharynxkarzinomen. Ein vorläufiger Erfahrungsbericht.